Quick Answer
Renalytix plc reported Operating Income Loss of -$29.61 million for the year ending 2024.
- Renalytix plc showed an increase of +29.9% in Operating Income Loss from 2023 to 2024.
- This data is from Renalytix plc's annual report (Form 10-K), filed with the SEC on September 30, 2024.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: -$11.72 million | Q4 2022: -$9.65 million | Q1 2023: -$10.92 million | Q3 2023: -$8.89 million | Q4 2023: -$8.64 million | Q1 2024: -$6.55 million | Q3 2024: -$4.09 million.
- Over the full 6 years of available data (2019 to 2024), Renalytix plc's Operating Income Loss has grown by 30.1%.
- Historical annual values: Fiscal year 2024: -$29.61 million | Fiscal year 2023: -$42.22 million | Fiscal year 2022: -$53.18 million | Fiscal year 2021: -$31.92 million | Fiscal year 2020: -$10.32 million | Fiscal year 2019: -$42.34 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: